# Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging

> **NCT00905879** · — · COMPLETED · sponsor: **Bayer** · enrollment: 30 (actual)

## Conditions studied

- Magnetic Resonance Imaging

## Interventions

- **DRUG:** Gadobutrol (Gadovist, BAY86-4875)

## Key facts

- **NCT ID:** NCT00905879
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** —
- **Final completion:** 2011-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905879, "Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00905879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*